NO890364L - Fremgangsmaate for fremstilling av pyraziner, pyrimidiner og pyridaziner. - Google Patents

Fremgangsmaate for fremstilling av pyraziner, pyrimidiner og pyridaziner.

Info

Publication number
NO890364L
NO890364L NO89890364A NO890364A NO890364L NO 890364 L NO890364 L NO 890364L NO 89890364 A NO89890364 A NO 89890364A NO 890364 A NO890364 A NO 890364A NO 890364 L NO890364 L NO 890364L
Authority
NO
Norway
Prior art keywords
pyridazines
pyrazines
pyrimidines
procedure
preparation
Prior art date
Application number
NO89890364A
Other languages
English (en)
Norwegian (no)
Other versions
NO890364D0 (no
Inventor
Raymond Baker
John Saunders
Leslie J Street
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888802101A external-priority patent/GB8802101D0/en
Priority claimed from GB888815225A external-priority patent/GB8815225D0/en
Priority claimed from GB888817812A external-priority patent/GB8817812D0/en
Priority claimed from GB888821088A external-priority patent/GB8821088D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of NO890364D0 publication Critical patent/NO890364D0/no
Publication of NO890364L publication Critical patent/NO890364L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO89890364A 1988-01-30 1989-01-27 Fremgangsmaate for fremstilling av pyraziner, pyrimidiner og pyridaziner. NO890364L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB888802101A GB8802101D0 (en) 1988-01-30 1988-01-30 Therapeutic agents
GB888815225A GB8815225D0 (en) 1988-06-27 1988-06-27 Therapeutic agents
GB888817812A GB8817812D0 (en) 1988-07-26 1988-07-26 Therapeutic agents
GB888821088A GB8821088D0 (en) 1988-09-08 1988-09-08 Therapeutic agents

Publications (2)

Publication Number Publication Date
NO890364D0 NO890364D0 (no) 1989-01-27
NO890364L true NO890364L (no) 1989-07-31

Family

ID=27450036

Family Applications (1)

Application Number Title Priority Date Filing Date
NO89890364A NO890364L (no) 1988-01-30 1989-01-27 Fremgangsmaate for fremstilling av pyraziner, pyrimidiner og pyridaziner.

Country Status (10)

Country Link
EP (1) EP0327155A3 (de)
JP (1) JPH02111768A (de)
KR (1) KR890011860A (de)
AU (1) AU622141B2 (de)
DK (1) DK35389A (de)
FI (1) FI890419A7 (de)
IL (1) IL89034A0 (de)
NO (1) NO890364L (de)
NZ (1) NZ227684A (de)
PT (1) PT89523B (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8808433D0 (en) * 1988-04-11 1988-05-11 Merck Sharp & Dohme Therapeutic agents
US5177084A (en) * 1989-08-08 1993-01-05 Merck Sharp & Dohme Ltd. Therapeutic use of substituted benzenes, formulations thereof and novel substituted benzenes
GB8918060D0 (en) * 1989-08-08 1989-09-20 Merck Sharp & Dohme Therapeutic agents
ATE153024T1 (de) * 1989-08-16 1997-05-15 Beecham Group Plc Azabicyclische verbindungen
GB9005737D0 (en) * 1990-03-14 1990-05-09 Beecham Group Plc Novel compounds
DK72790D0 (da) * 1990-03-21 1990-03-21 Ferrosan As Heterocycliske forbindelser, deres fremstilling og anvendelse
GB9017353D0 (en) * 1990-08-08 1990-09-19 Merck Sharp & Dohme Chemical process
CA2050264A1 (en) * 1990-08-30 1992-03-01 Raymond Baker Substituted pyrazine and its salts, compositions containing them and their use in medicine
EP0492903A1 (de) * 1990-12-21 1992-07-01 MERCK SHARP &amp; DOHME LTD. Substituierte Pyrazine, Pyrimidine und Pyridazine zur Anwendung in der Behandlung von Glaukoma
EP0492902A1 (de) * 1990-12-21 1992-07-01 MERCK SHARP &amp; DOHME LTD. Substituierte Pyridine zur Anwendung in der Behandlung von Glaukoma
GB9201749D0 (en) * 1992-01-28 1992-03-11 Smithkline Beecham Plc Medicaments
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU672644B2 (en) * 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
AU671163B2 (en) * 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
WO1997019669A2 (en) * 1995-11-29 1997-06-05 Eli Lilly And Company Heterocyclic compounds and their use
US5889019A (en) * 1995-11-29 1999-03-30 Eli Lilly And Company Heterocyclic compounds and their use
US5834458A (en) * 1996-10-09 1998-11-10 Eli Lilly And Company Heterocyclic compounds and their use
US5733912A (en) * 1997-02-19 1998-03-31 Abbott Laboratories 7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission
CA2287223A1 (en) * 1997-04-26 1998-11-05 Tomohiro Toyoda 2-azabicyclo compounds
CN1231473C (zh) * 2000-02-16 2005-12-14 神经能质公司 取代的芳基吡嗪
US20060025468A1 (en) * 2004-07-29 2006-02-02 Whitten Jeffrey P Chiral pyrrolidine derivatives, and methods for preparing compounds thereof
JP2007032031A (ja) * 2005-07-25 2007-02-08 Sanyo Industries Ltd 持出し手摺構造及びその取付け方法
KR102636383B1 (ko) 2017-08-04 2024-02-14 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
CN119320388A (zh) * 2019-02-04 2025-01-17 斯基霍克疗法公司 用于调节剪接的方法和组合物
WO2020163382A1 (en) * 2019-02-04 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing
JP7551629B2 (ja) 2019-02-05 2024-09-17 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
KR102913697B1 (ko) 2019-02-05 2026-01-15 스카이호크 테라퓨틱스, 인코포레이티드 스플라이싱을 조절하는 방법 및 조성물
JP7603594B2 (ja) 2019-02-06 2024-12-20 スカイホーク・セラピューティクス・インコーポレーテッド スプライシングを調節するための方法および組成物
WO2020163544A1 (en) 2019-02-06 2020-08-13 Skyhawk Therapeutics, Inc. Methods and compositions for modulating splicing

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4911710A (de) * 1972-05-15 1974-02-01
CA1244028A (en) * 1983-04-14 1988-11-01 Hans Maag Pyrimidine derivatives
ZA842595B (en) * 1983-04-14 1985-11-27 Hoffmann La Roche Pyrimidine derivatives
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
EP0287356B1 (de) * 1987-04-15 1996-01-24 Beecham Group Plc Am Brückenkopf substituierte Azabicyclenderivate
CA2000041A1 (en) * 1988-10-13 1990-04-13 Barry S. Orlek Compounds

Also Published As

Publication number Publication date
FI890419A0 (fi) 1989-01-27
AU622141B2 (en) 1992-04-02
JPH02111768A (ja) 1990-04-24
EP0327155A3 (de) 1992-01-02
PT89523B (pt) 1994-02-28
PT89523A (pt) 1989-10-04
AU2883489A (en) 1989-08-03
DK35389D0 (da) 1989-01-27
FI890419A7 (fi) 1989-07-31
EP0327155A2 (de) 1989-08-09
NO890364D0 (no) 1989-01-27
IL89034A0 (en) 1989-08-15
DK35389A (da) 1989-07-31
NZ227684A (en) 1991-07-26
KR890011860A (ko) 1989-08-23

Similar Documents

Publication Publication Date Title
NO890364D0 (no) Fremgangsmaate for fremstilling av pyraziner, pyrimidiner og pyridaziner.
NO892083L (no) Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner.
NO904921D0 (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
NO882762D0 (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske forbindelser.
NO891369L (no) Fremstilling og anvendelse av kondenserte pyrimidiner.
NO902750D0 (no) Fremgangsmaate til fremstilling av 3,5,6-substituerte derivater av 1,2-0-isopropyliden-alfa-glukofuranose og mellomprodukter for fremstilling av derivatene.
NO894088D0 (no) Pyridazinonderivater.
NO911432D0 (no) Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler.
FI890888A0 (fi) Framstaellning av r- och s-amlodipin.
NO890894L (no) 4-substituerte pyrazolo(3,4-alfa)pyrimidinderivater og fremgangsmaate for deres fremstilling.
NO893826D0 (no) Fremgangsmaate for fremstilling av 2&#39;-halomethyliden, 2&#39;-ethenyliden og 2&#39;-ethenyladenosinderivater.
NO900643L (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO892499D0 (no) 2,5,6,7-tetranor-4,8-inter-m-fenylen pgi2 derivater, fremgangsmaate for fremstilling av disse, og anvendelse derav.
NO893064L (no) Sekundaere polyeteraminer, deres fremstilling og anvendelse for fremstilling av polyureaforbindelser.
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
EP0311634A4 (de) 6-(6-alkylpyridon)-carbostyril-verbindungen und deren kardiotonische verwendungen.
NO904805D0 (no) Fremgangsmaate for fremstilling av antihypertensive og antiarytmiske pyridinderivater.
NO881713D0 (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO891985L (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
ATE48275T1 (de) Cardiotonische heterocyclocarbonyl- und acetylthiazolone.
NO166726C (no) Fremgangsmaate for fremstilling av arylglycidyletere og 3-substituerte 1-alkylamino-2-propanoler.
NO911252D0 (no) Benzoksazinderivater, fremgangsmaate for fremstilling derav, samt anvendelse av derivatene.
NO905543D0 (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
NO903484D0 (no) Substituerte pyrazinderivater og fremgangsmaate for deres fremstilling.
NO892468D0 (no) Fremgangsmaate for fremstilling av polyuretanskum.